Minimizing side effects from chemoradiation could help brain cancer patients live longer

	Tweet

Minimizing neurological side effects in patients with high-grade glioma from chemoradiation may result in improved patient survival, a new study from radiation oncologists at the Kimmel Cancer Center at Jefferson suggests. These findings were reported in the April issue of the British Journal of Cancer.

The researchers found that the occurrence of early side effects, such as fatigue and loss of short-term memory, that manifest during or soon after treatment is significantly associated with both late side effects (after 90 days) and overall survival in patients who suffer from malignant brain tumors, such as glioblastoma.

High-grade glioma patients who did not experience neurological side effects during chemoradiation for the brain cancer were found to have lived 4 months longer compared to those who did experience such effects.

The findings suggest the importance of normal tissue damage in determining long-term survival and how minimizing side effects could end in more positive outcomes.

The team reports their findings from a retrospective analysis of high-grade glioma patients from the Radiation Therapy Oncology Group (RTOG) database.

“As survival in glioblastoma multiforme increases, the prevention of treatment related side-effects becomes more important,” said Yaacov Richard Lawrence, MRCP, an Assistant Professor in the Department of Radiation Oncology at Thomas Jefferson University and director of the Center for Translational Research in Radiation Oncology at Sheba Medical Center in Israel.

“It is generally considered that the only way to improve survival in malignant brain tumors is to more effectively attack the tumor,” Dr. Lawrence said. “Fascinatingly, our research suggests that damage to surrounding normal tissue may also play a role in determining a patient’s long term outcome.”

There are approximately 17,000 primary brain tumors diagnosed in the United States each year, 60 percent of which are gliomas. The most common and malignant glioma is glioblastoma, the type of brain cancer Senator Ted Kennedy was diagnosed with and died from.

Standard treatment for the cancer typically includes surgery, radiation and chemotherapy after the tumor is identified. It is often impossible to determine whether these treatments, the combination of these treatments or the tumor itself cause neurological symptoms, which include fatigue, headache, nausea, motor/sensory disturbance, short-term memory loss and/or seizures.

For the study, researchers analyzed data amongst 2,761 patients from 14 RTOG radiation therapy glioma studies that accrued patients from 1983 to 2003. Patients considered were more likely to have side effects if they were older, frailer, had more symptoms, and were receiving radiation twice daily.

“Our results support the personalized approach to brain tumor management currently being developed within the Jefferson Multidisciplinary Brain Clinic, and emphasize the importance of minimizing side effects,” Dr. Lawrence said.

###

Contact: Steve Graff

215-955-5291
Thomas Jefferson University

RELATED STORIES:
IMRT improves outcomes in patients with extranodal lymphoma of the head and neck   Study Compares Treatment Options for Patients with Brain Metastases   Target for Therapeutic Drugs to Fight Most Common Adult Brain Cancer   Sensitizing tumor response to cancer therapy   Early detection critical in treating pediatric thyroid cancer   Immune deficiency linked to a type of eye cancer   Novel Suicide Gene Therapy Used to Treat Malignant Brain Tumors   Combining radiation therapy, chemotherapy safely treats head and neck cancer patients   Certain head and neck cancer patients benefit from second round of treatment   HPV-Positive Tumor Status Indicates Better Survival in Patients with Oropharyngeal Cancer   New technique holds promise for rare eye cancer   Alcohol and cancer: is drinking the new smoking?   Brain tumors: New therapy surprisingly successful   Some brain tumors mimic the genetic program of germline cells   Genetics of children’s brain tumour unlocked   Researchers link dental x-rays to brain tumours   Antidepressant may help head/neck cancer patients   Cotton-Seed Based Drug Shows Promise in Treating Severe Brain Cancer   Cancer Researcher Offer New Hope for Brain Tumor   Researchers Pinpoint Origin of Deadly Brain Tumor   Study identifies 5 risk factors for late-stage head and neck cancer   Brain tumor discovery could lead to new treatment

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]